A Study of GENEVAX-HIV, a Possible Vaccine
NCT00002232 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL
Last updated 2005-06-24
Summary
The purpose of this study is to see if it is safe to give GENEVAX-HIV, a potential HIV vaccine, to HIV-negative volunteers. The study also compares the effects of GENEVAX-HIV injected into the muscle to the effects of the drug when injected into the skin.
Conditions
- HIV Infections
- HIV Seronegativity
Interventions
- BIOLOGICAL
-
APL 400-003
Sponsors & Collaborators
-
Wyeth-Lederle Vaccines
lead INDUSTRY
Principal Investigators
-
Merlin Robb
Study Design
- Purpose
- PREVENTION
- Masking
- DOUBLE
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
Countries
- United States
Study Locations
More Related Trials
-
A Study of AIDSVAX B/B and AIDSVAX B/E, Two Possible Vaccines
NCT00002402 ·Status: COMPLETED ·Phase: PHASE1
-
Safety of and Immune Response to an HIV DNA Plasmid Vaccine Followed by HIV Adenoviral Vector Vaccine in Healthy African Adults
NCT00415649 ·Status: WITHDRAWN ·Phase: PHASE2
-
Evaluating the Safety and Immune Response to Three Different DNA HIV Vaccines Administered With a MVA-CMDR Boost Vaccine in Healthy, HIV-Uninfected Adults
NCT02296541 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluating the Safety of and Immune Response to the VSV-Indiana HIV Vaccine in Healthy, HIV-Uninfected Adults
NCT01438606 ·Status: COMPLETED ·Phase: PHASE1
-
Safety of and Immune Response to a Modified Vaccinia Ankara (MVA) HIV Vaccine in HIV Uninfected Adults
NCT00376090 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Effectiveness of an HIV DNA Vaccine Followed by an HIV Adenoviral Vector Vaccine for Prevention of HIV Infection in the Americas and Africa
NCT00498056 ·Status: WITHDRAWN ·Phase: PHASE2
-
Safety and Immunogenicity of Recombinant Varicella Zoster Virus Vaccine in People With HIV Who Have a CD4 Count Less Than 300 or Greater Than or Equal to 300 and a Healthy Control Population
NCT05580458 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Evaluating the Safety of and Immune Response to an HIV Vaccine Followed by Booster, Administered by Two Devices, in HIV-Uninfected Adults
NCT01260727 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluating the Safety and Immune Response to Five Different Combinations of HIV Vaccines in Healthy, HIV-Uninfected Adults
NCT01964937 ·Status: WITHDRAWN ·Phase: PHASE1
-
Evaluating the Immunogenicity of the AIDSVAX B/E Vaccine and the MVA/HIV62B Vaccine in Healthy, HIV-1-Uninfected Adults Who Previously Received MVA/HIV62B in DNA/MVA or MVA/MVA Regimens in HVTN 205
NCT02852005 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluating the Safety, Tolerability, and Immunogenicity of a Prime-Boost Regimen of HIV-1 Nef/Tat/Vif, Env pDNA Vaccine Delivered Intramuscularly With Electroporation and HIV-1 rVSV envC Vaccine in Healthy, HIV-Uninfected Adults
NCT02654080 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluating the Safety and Priming Response of an HIV Vaccine Regimen in Healthy, HIV-Uninfected Adults
NCT01799954 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Compare the Immunogenicity and Safety of Two HIV Preventive Vaccinations in Healthy Volunteers
NCT00490074 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Evaluate Tolerability of a Recombinant DNA HIV-1 Vaccine in Healthy Adults
NCT00187148 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Immunogenicity of HIVAX in HIV-1 Infected Subjects
NCT01428596 ·Status: UNKNOWN ·Phase: PHASE1
-
A Phase I Multicenter, Randomized, Double-Blind Trial to Evaluate the Safety and Immunogenicity of Recombinant Vaccinia Virus Expressing the Envelope Glycoproteins of Human Immunodeficiency Virus
NCT00000683 ·Status: COMPLETED ·Phase: PHASE1
-
Phase I Study of Vaccination Schedule of Experimental HIV Vaccines
NCT00321061 ·Status: COMPLETED ·Phase: PHASE1
-
Candidate HIV Vaccine
NCT00089531 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluating the Safety and Immune Response to an HIV Vaccine Boost Following the Administration of Two HIV Vaccines, in HIV-Uninfected, Healthy Adults (Study Extension to HVTN 073/SAAVI 102)
NCT01423825 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Immunogenicity Study of Recombinant Modified Vaccinia Virus Ankara (MVA) Virus to Treat HIV Infection
NCT00386633 ·Status: COMPLETED ·Phase: PHASE1
-
Effectiveness of an HIV Vaccine in HIV-Negative Adults in North America Who Are at Risk of HIV Infection
NCT00002441 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluating the Safety and Immune Response to Three Different Prime-Boost HIV Vaccine Regimens in Healthy, HIV-Uninfected Adults
NCT01970449 ·Status: WITHDRAWN ·Phase: PHASE1
-
Use of a Varicella-Zoster Virus (VZV) Vaccine to Prevent Shingles in HIV-Infected Children Who Have Already Had Chickenpox
NCT00001125 ·Status: COMPLETED ·Phase: PHASE1
-
HIV Vaccine Trial in Thai Adults
NCT00223080 ·Status: COMPLETED ·Phase: PHASE3
-
Phase I Safety Study of a Recombinant MVA HIV Multiantigen Vaccine in HIV-infected Subjects
NCT00623259 ·Status: COMPLETED ·Phase: PHASE1